Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for ...

The CIO Seminar goes far beyond traditional IT training. It positions the CIO as a central architect of corporate strategy, innovation, and value creation. A key differentiator of the program is its ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for ...

First patients dosed in budoprutug PrisMN Phase 2 trial in pMN, with initial data expected second half 2026 Dosing ongoing in ...

Estimated YUTREPIA™ net product sales of approximately $90.1 million in the fourth quarter and $148.3 million for full-year 2025Received more than 2,800 unique patient prescriptions since launch in ...

SAN DIEGO, CA / ACCESS Newswire / January 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...

Hydrolyzed Vegetable Protein Market is expected to reach US$ 5,110.8 Mn by 2035, driven by rising demand for plant-based ...

Balance Sheet and Sharpened Strategy VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / January 8, 2026 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(Frankfurt:LOBE.F) ("Lobe" or the "Company"), a biophar ...

Defense ministry says Taiwan prepared for Venezuela-style strike scenario Request To Download Free Sample of This Strategic Report @- Downstream processing involves the purification and recovery of ...

That responsibility sits with Brett Roosendaal, commercial nutrition executive at Rainbow Chicken Farms and speaker at New ...

Peer-reviewed publication in “The Oncologist” is now available onlineInvestigational same-day dosing of Rolvedon demonstrated a clinical response and adverse event profile similar to next-day ...

Limitless X Holdings Inc. (OTCQX: LIMX), a diversified global consumer products, wellness, entertainment, and lifestyle company founded by entrepreneur Jas Mathur, today announced that its Board of ...